0.47
0.47 (0%)
As of Apr 17, 2024
Prosomnus, Inc. [OSA]
Source:
Company Overview
Prosomnus, Inc is a medical technology company focused on the development, manufacturing and marketing of precision intraoral medical devices, a novel non-invasive option for treating and managing patients with obstructive sleep apnea.
| Country | United States |
| Headquarters | pleasanton, california |
| Phone Number | ( 844 ) 537-5337 |
| Industry | manufacturing |
| CEO | Len Liptak |
| Website | www.prosomnus.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $9.1 |
| Operating Profit | $-2.2 |
| Net Income | $-15.2 |
| Net Cash | $-1.8 |
Profit Ratios
| Gross Margin | $4.8 |
| Operating Margin | -24.7 |
| Profit as % of Revenues | -31.8% |
| Profit as % of Assets | -85.5% |
| Profit as % of Stockholder Equity | 31% |
Management Effectiveness
| Return on Equity | 31% |
| Return on Assets | -57.5% |
| Turnover Ratio | 51.2% |
| EBITA | $-2.2 |
Balance Sheet and Cash Flow Measures
| Total Assets | $26.4 |
| Total Liabilities | $63.9 |
| Operating Cash Flow | $-10.3 |
| Investing Cash Flow | $-0.4 |
| Financing Cash Flow | $9 |
